Wednesday, 24 August 2022 9:07 amIt would appear Johnson & Johnson was also circling US-listed Global Blood Therapeutics, which two weeks ago agreed a deal to sell itself to pharmaceutical giant Pfizer for $5.4 billion.
Thursday, 04 August 2022 8:08 amGlobal Blood Therapeutics, a US-listed biopharmaceutical company, is a business that has been on Betaville's radar for quite a few years amid vague rumours.
